000			01882 a2200565 4500
005			20250516002208.0
264		0	_c20110404
008			201104s 0 0 eng d
022			_a0399-8320
024	7		_a10.1016/j.gcb.2010.07.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aBaudet, A
245	0	0	_aA fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks. _h[electronic resource]
260			_bGastroenterologie clinique et biologique _cNov 2010
300			_a612-7 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aColectomy _xmethods
650	0	4	_aColitis, Ulcerative _xdiagnosis
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aInfliximab
650	0	4	_aIntestinal Mucosa _xpathology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPredictive Value of Tests
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSensitivity and Specificity
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aColombel, J-F
700	1		_aCortot, A
700	1		_aDupas, J-L
700	1		_aBrazier, F
700	1		_aSavoye, G
700	1		_aLerebours, E
700	1		_aJustum, A-M
700	1		_aReimund, J-M
773	0		_tGastroenterologie clinique et biologique _gvol. 34 _gno. 11 _gp. 612-7
856	4	0	_uhttps://doi.org/10.1016/j.gcb.2010.07.013 _zAvailable from publisher's website
999			_c20164268 _d20164268